-
Treatment Patterns and Healthcare Costs of Newly Diagnosed Type 1 Diabetes Patients: A Retrospective Real-World Study of Hospital Care in Tianjin, China
Sep 9, 2025, 16:22 PM -
Lipid-Lowering Prescription Patterns After a Nonfatal Acute Coronary Syndrome: The Impact of Real-World Evidence on Clinical Practice With LATINO-ACS 2.0
Sep 9, 2025, 16:22 PM -
Disease Burden of MASH/MASLD Among People With Obesity in China, Japan, and EU5
Sep 9, 2025, 16:22 PM -
Exploring Quality of Life in Duchenne Muscular Dystrophy: Insights From Qualitative Patient and Caregiver Interviews
Sep 9, 2025, 16:22 PM -
Outcome Measures Relevant for Assessing Health-Related Quality of Life and Utility in Primary Lateral Sclerosis (PLS)
Sep 9, 2025, 16:22 PM -
Health Technology Assessment Landscape for Medical Devices in Europe
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Sep 9, 2025, 16:22 PM -
Applicability of the STEDI Value Framework to Vaccines in Health Technology Assessment: Opportunities and Considerations
Sep 9, 2025, 16:22 PM -
Patient Characteristics and Treatment Comparison Among Patients With Chronic Obstructive Pulmonary Disease: Real-World Evidence From Sweden
Sep 9, 2025, 16:22 PM -
Approaches Used in Assessing the Environmental Sustainability of Digital Health Technologies: A Systematic Review
Sep 9, 2025, 16:22 PM -
Does the Joint Clinical Assessment (JCA) Enable Health Equity Across Europe? A Review of HTA Practices in the EU
Sep 9, 2025, 16:22 PM -
An Economic Evaluation to Inform the Use of Enhanced Influenza Vaccines for Those Aged 65 Years and Older in the Seasonal Influenza Vaccination Program in Ireland
Sep 9, 2025, 16:22 PM -
Assessing the Clinical Impact of Decreasing Weight in Young Adults Using the Metabo-Reno-Cardiovascular Disease Model©
Sep 9, 2025, 16:22 PM -
Cardiovascular Event Rate and Mortality Among Primary-Prevention Hypercholesterolemia Patients in Japan
Sep 9, 2025, 16:22 PM -
An Initiative to Improve Patient Organization Engagement at the National Center for Pharmacoeconomics, Ireland
Sep 9, 2025, 16:22 PM -
Utilizing the Patient-Specific Needs Evaluation for Data-Supported and Individualized Treatment (UNITE)
Sep 9, 2025, 16:22 PM -
Assessing Readiness for the EU-HTA Regulation: Insights From Market Access Experts Across Europe
Sep 9, 2025, 16:22 PM -
Institutional Trends and Healthcare Resource Utilization in Real-World NMIBC and MIBC Treatment in Germany
Sep 9, 2025, 16:22 PM -
Evaluating the Role of Patient-Reported Outcomes in Phase 4 Clinical Trials: Trends, Applications, and Implications for Postmarketing Surveillance
Sep 9, 2025, 16:22 PM -
Association of eGFR Decline and Cardiovascular Outcomes in Chronic Kidney Disease Patients: Feasibility of Frequency Matching Replicating Event-Driven Clinical Trials With Real-World Data Long-Term
Sep 9, 2025, 16:22 PM
